Aripiprazole cas: 129722-12-9

CAS NO: 129722-12-9
Aripiprazole
Description Review
Description

Aripiprazole is a medication used to treat mental health conditions like schizophrenia, bipolar disorder, and major depressive disorder. It belongs to the class of drugs called atypical antipsychotics that work by balancing the levels of certain chemicals in the brain.

Chemical name: The chemical name of aripiprazole is 7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-3,4-dihydroquinolin-2(1H)-one.

Molecular formula: The molecular formula of aripiprazole is C23H27Cl2N3O2.

Formula weight: The molecular weight of aripiprazole is 448.39 g/mol.

CAS No: The CAS number of aripiprazole is 129722-12-9.

Top ten keywords from Google and synonyms:

  1. Schizophrenia
  2. Bipolar disorder
  3. Major depressive disorder
  4. Atypical antipsychotics
  5. Dopamine receptors
  6. Serotonin receptors
  7. Neurotransmitters
  8. Psychosis
  9. Mood disorders
  10. Antidepressants

Synonyms: • Aripiprazole Hydrochloride • Abilify • OPC-14597 • 7-{4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy}-3,4-dihydro-2(1H)-quinolinone

Health benefits of this product: Aripiprazole helps manage symptoms of schizophrenia, bipolar disorder, and major depressive disorder. By balancing the levels of dopamine and serotonin in the brain, aripiprazole reduces hallucinations, delusions, and other symptoms of psychosis. In addition, aripiprazole may also improve mood and reduce anxiety in patients with mood disorders.

Potential effects: Aripiprazole can cause side effects like drowsiness, nausea, vomiting, constipation, and akathisia (restlessness). In rare cases, it may lead to tardive dyskinesia (involuntary muscle movements) or neuroleptic malignant syndrome (a life-threatening condition). Aripiprazole can also interact with certain medications, causing adverse effects or reducing their efficacy. Patients should inform their healthcare provider about all the prescription and non-prescription medications they are taking before starting aripiprazole.

Product mechanism: Aripiprazole works by blocking certain dopamine and serotonin receptors in the brain, thereby regulating the levels of these neurotransmitters. By balancing the levels of dopamine and serotonin, aripiprazole reduces symptoms of psychosis and mood disorders.

Safety: Aripiprazole is generally safe when taken as prescribed by a healthcare professional. However, patients with a history of liver or kidney disease, heart disease, seizures, or diabetes should avoid using aripiprazole. Pregnant or breastfeeding women should also avoid aripiprazole unless prescribed by a healthcare professional.

Side effects: The most common side effects of aripiprazole include drowsiness, nausea, vomiting, constipation, and akathisia (restlessness). In rare cases, it may lead to tardive dyskinesia (involuntary muscle movements) or neuroleptic malignant syndrome (a life-threatening condition).

Dosing information: The recommended dose of aripiprazole varies depending on the condition being treated and the patient's age and weight. The usual starting dose for adults with schizophrenia or bipolar disorder is 10-15 mg/day, while the maximum daily dose is 30 mg/day. For children and adolescents with schizophrenia or bipolar disorder, the starting dose is usually 2 mg/day, while the maximum daily dose is 10 mg/day.

Conclusion: Aripiprazole is an effective medication for managing symptoms of schizophrenia, bipolar disorder, and major depressive disorder. By balancing the levels of dopamine and serotonin in the brain, aripiprazole reduces hallucinations, delusions, and other symptoms of psychosis. Although generally safe, aripiprazole may cause adverse effects like drowsiness, nausea, vomiting, and constipation. Patients should inform their healthcare provider about all the prescription and non-prescription medications they are taking before starting aripiprazole

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code